wiki pageCreated: 2026-04-02T07:19:07By: crosslink-migrationQuality:
50%✓ SciDEXID: wiki-proteins-fermity
📖 Wiki Page
protein594 wordssynced 2026-04-02
Fermitin-2 Protein (FERMT2)
Introduction
Fermitin 2 Protein (Kindlin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Fermitin-2, also known as Kindlin-2, is a member of the fermitin/kindlin family of proteins that play critical roles in integrin activation and cell-matrix adhesion. Fermitin-2 is widely expressed in various tissues including the brain, where it regulates integrin-mediated signaling important for neuronal survival and [blood-brain barrier](/entities/blood-brain-barrier) (BBB) function.<sup>[1]</sup>
...
Fermitin-2 Protein (FERMT2)
Introduction
Fermitin 2 Protein (Kindlin 2) is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Fermitin-2, also known as Kindlin-2, is a member of the fermitin/kindlin family of proteins that play critical roles in integrin activation and cell-matrix adhesion. Fermitin-2 is widely expressed in various tissues including the brain, where it regulates integrin-mediated signaling important for neuronal survival and [blood-brain barrier](/entities/blood-brain-barrier) (BBB) function.<sup>[1]</sup>
Structure
Fermitin-2 is a 683 amino acid protein with a characteristic domain architecture:
N-Terminal FERM Domain: Contains subdomains F1, F2, and F3 (4.1/ezrin/radixin/moesin homology) that mediate protein-protein and protein-lipid interactions
PH Domain: Pleckstrin homology domain for membrane localization through phosphoinositide binding
Proline-Rich Region: Contains binding sites for SH3 domain-containing proteins
The FERM domain binds to integrin β cytoplasmic tails, while the PH domain targets the protein to the plasma membrane.
Cooperates with talin to activate integrins by binding to integrin β cytoplasmic tails<sup>[2]</sup>
Induces conformational changes that increase integrin affinity for extracellular matrix ligands
Essential for inside-out integrin signaling
Cell-Matrix Adhesion
Critical for formation and maintenance of focal adhesions
Links integrins to the actin cytoskeleton
Regulates focal adhesion turnover during cell migration
Brain Functions
Expressed in endothelial cells where it regulates BBB integrity
Present in [neurons](/entities/neurons) where it may influence synaptic function
Involved in astrocyte-endothelial interactions
Role in Disease
Alzheimer's Disease
FERMT2 has been identified as a genetic risk factor for late-onset Alzheimer's disease (LOAD) through GWAS.<sup>[3]</sup>
Disease Mechanisms:
Blood-Brain Barrier: Fermitin-2 in endothelial cells may regulate BBB integrity; variants could affect BBB dysfunction in AD<sup>[4]</sup>
Neuroinflammation: Modulates microglial adhesion and migration to sites of pathology
Synaptic Adhesion: Integrin-mediated adhesion at synapses; fermitin-2 may affect synaptic stability
Cancer
Fermitin-2 is frequently overexpressed in various cancers and is associated with tumor progression and metastasis.
Therapeutic Targeting
Strategies for targeting fermitin-2 in AD:
BBB Protection: Developing compounds that enhance endothelial fermitin-2 function to maintain BBB integrity
Integrin Modulation: Targeting integrin-fermitin-2 interactions to improve neuronal survival
Anti-inflammatory: Modulating microglial adhesion and migration
Background
The study of Fermitin 2 Protein (Kindlin 2) has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
<sup><a href="https://pubmed.ncbi.nlm.nih.gov/19403593/">[1]</a></sup> Fermitin family members in cell adhesion. PMID: 19403593(https://pubmed.ncbi.nlm.nih.gov/19403593/)
<sup>[1]</sup> Rognoni E, et al. Kindlin-2: a novel regulator of integrin signaling. Cell Cycle. 2014;13(4):530-535.
<sup>[2]</sup> Ma YQ, et al. Kindlin-2 (Mig-2) regulates integrin activation. J Cell Sci. 2011;124(Pt 7):1043-1052.
<sup>[3]</sup> Lambert JC, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet. 2013;45(12):1452-1458.
<sup>[4]</sup> Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease. Nat Rev Neurosci. 2011;12(12):723-738.